Targeting of DNMT3B in the plasma cell cancer multiple myeloma disturbs cancer cell growth and clonogenicity and boosts the anti-tumor activity of the proteasome inhibitor bortezomib

Prijs: Prize (including medals and awards)

Description

Best poster award - First place
Datum van toekenning30 sep 2022

Toegekend op evenement

EvenementstitelBelgian association for cancer research
LocatieGhent
Periode30 sep 2022 → 30 sep 2022

    Vingerafdruk

Gerelateerde inhoud